Parameter Utility Value Sources/Assumptions
Age-specific utilities   [19]
30-39 years 0.940  
40-49 years 0.930  
50-59 years 0.920  
60-69 years 0.910  
70-79 years 0.910  
80+ years 0.880  
Health state–specific utilities    
Healthy men: no PCa or BPH 1.000 Assumption
BPH 0.963 [17]
PCa: high-grade cancera 0.760 [18]
PCa: low-grade cancera 0.840 [18]
Death 0.000 Assumption
Utility decrements/improvements    
BPH symptom improvement due to use of dutasteride 0.018 [17]
AUR 0.003 [17]
BPH-related surgery 0.0005 [17]
Ejaculatory dysfunction 0.007 [17]
Impotence 0.029 [17]
Hospitalization due to UTI 0.00058 [17]
AUR = acute urinary retention; BPH = benign prostatic hyperplasia; PCa = prostate cancer; UTI = urinary tract infection. aUtilities for high-grade and low-grade tumors consider adverse events that may occur due to PCa treatment.
Table 1: Utility Weights and Utility Decrements for Calculating Quality-Adjusted Life-years.